India’s generic medicines steal the spotlight as US exempts pharma from tariffs
India’s pharma sector has emerged as a big winner amid Trump’s tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs, recognizing the vital role of India’s generic medicines…
Mankind Pharma faces Rs 183 crore tax demand, plans to appeal
Mankind Pharma has received tax demand orders from the Income Tax Department for Assessment Years (AY) 2014-15 to 2017-18, amounting to ₹183.11 crore, including interest. The demand arises from the…
India’s Pharma Industry Raises Concerns Of Shortage & Costlier Medicine For Americans Over Proposed US Tariffs
The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential…
India is not ready with an infrastructure whereby generics could replace branded: Anil Matai
Anil Matai: Director General, Organisation of Pharmaceutical Producers of India (OPPI) in an exclusive interaction with ETHealthworld’s Rashmi Mabiyan Kaur elucidates on the key aspects that can enable the Indian pharmaceutical industry to move…